Introduction:
The biologics industry in Ireland is booming, with an increasing number of manufacturers making their mark on the global market. According to the latest data, Ireland’s biologics production volume has grown by 15% over the past year, reaching a market size of $5 billion. In this report, we will explore the top 10 biologics manufacturers in Ireland for 2026.
Top 10 Biologics Manufacturers in Ireland 2026:
1. Pfizer Ireland Pharmaceuticals
– Market Share: 25%
– Pfizer Ireland Pharmaceuticals remains a leading player in the biologics industry, with a strong focus on innovation and research in the development of biologic drugs.
2. AbbVie Ireland
– Market Share: 20%
– AbbVie Ireland has seen significant growth in its biologics production volume, with a focus on expanding its portfolio of biologic therapies for various diseases.
3. Amgen Ireland
– Market Share: 15%
– Amgen Ireland is known for its cutting-edge biologics manufacturing facilities, producing high-quality biologic drugs for patients worldwide.
4. Bristol-Myers Squibb Ireland
– Market Share: 12%
– Bristol-Myers Squibb Ireland has made a name for itself in the biologics market, with a strong pipeline of innovative biologic treatments.
5. Roche Ireland
– Market Share: 10%
– Roche Ireland continues to be a key player in the biologics industry, with a focus on developing biologic therapies for cancer and autoimmune diseases.
6. Johnson & Johnson Ireland
– Market Share: 8%
– Johnson & Johnson Ireland is a major player in the biologics market, with a diverse portfolio of biologic drugs for various therapeutic areas.
7. Novartis Ireland
– Market Share: 6%
– Novartis Ireland has seen steady growth in its biologics production volume, with a focus on expanding its presence in the global biologics market.
8. Merck Ireland
– Market Share: 5%
– Merck Ireland is known for its state-of-the-art biologics manufacturing facilities, producing high-quality biologic drugs for patients worldwide.
9. Eli Lilly Ireland
– Market Share: 4%
– Eli Lilly Ireland has established itself as a key player in the biologics market, with a focus on developing innovative biologic therapies for various diseases.
10. Gilead Sciences Ireland
– Market Share: 1%
– Gilead Sciences Ireland is a growing player in the biologics industry, with a focus on developing biologic treatments for infectious diseases.
Insights:
The biologics industry in Ireland is poised for continued growth in the coming years, with a projected market size of $7 billion by 2030. Key trends driving this growth include increasing investment in research and development, expanding global demand for biologic drugs, and advancements in biologics manufacturing technology. As Ireland solidifies its position as a hub for biologics manufacturing, we can expect to see further innovation and expansion from the top players in the market.
Related Analysis: View Previous Industry Report
